Cargando…
Differential Gene Expression Profile Induced by Valproic Acid (VPA) in Pediatric Epileptic Patients
Epilepsy is a neuronal disease that affects up to 70 million people worldwide. The development of effective therapies to combat childhood epilepsy requires early biomarkers. Here, we performed a whole-genome microarray analysis in blood cells to identify genes differentially expressed between epilep...
Autores principales: | Floriano-Sánchez, Esaú, Brindis, Fernando, Ortega-Cuellar, Daniel, Ignacio-Mejía, Ivan, Moreno-Arriola, Elizabeth, Romero-Morelos, Pablo, Ceballos-Vasquez, Edgar, Córdova-Espinoza, María Guadalupe, Arregoitia-Sarabia, Cindy Karel, Sandoval-Pacheco, Roberto, Carmona-Aparicio, Liliana, Cárdenas-Rodríguez, Noemí |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6070821/ https://www.ncbi.nlm.nih.gov/pubmed/29958461 http://dx.doi.org/10.3390/genes9070328 |
Ejemplares similares
-
Effects of Valproate Monotherapy on the Oxidant-Antioxidant Status in Mexican Epileptic Children: A Longitudinal Study
por: Beltrán-Sarmiento, Eduardo, et al.
Publicado: (2018) -
The Anti-Epileptic Drug Valproic Acid (VPA) Inhibits Steroidogenesis in Bovine Theca and Granulosa Cells In Vitro
por: Glister, Claire, et al.
Publicado: (2012) -
Modulation of Antioxidant Enzymatic Activities by Certain Antiepileptic Drugs (Valproic Acid, Oxcarbazepine, and Topiramate): Evidence in Humans and Experimental Models
por: Cárdenas-Rodríguez, Noemí, et al.
Publicado: (2013) -
Exposure to valproic acid (VPA) reproduces
hdac1
loss of function phenotypes in zebrafish
por: Jones, Alec A., et al.
Publicado: (2023) -
Valproic acid (VPA) in patients with refractory advanced cancer: a dose escalating phase I clinical trial
por: Atmaca, A, et al.
Publicado: (2007)